Xtant Medical Holdings, Inc.
$0.32
-$0.01 (-2.14%)
$0.32Day Range$0.33
Key Statistics
Market Cap
$44.89M
Shares Outstanding
140.3M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jan 31, 2007
Round Lot
100
Locale
US
Trading Data
Day Open
$0.33
Day High
$0.33
Day Low
$0.32
Volume
207.1K
VWAP
$0.32
Prev Close
$0.33
Transactions
--
Acc. Volume
--
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841151 employees664 CRUISER LANE, BELGRADE, MT, 59714406-388-0480IPO Jan 31, 2007US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001453593
- Composite FIGI
- BBG000Q44D18
- Share Class FIGI
- BBG001T6FJR5
- Ticker Root
- XTNT
- SIC Code
- 3841
About Xtant Medical Holdings, Inc. (XTNT) Stock
Xtant Medical Holdings, Inc. (XTNT) closed the 2026-09-18 session at $0.32, down 2.14% versus the previous close (-0.01). The stock opened at $0.33 and traded between $0.32 and $0.33 during that session. Session trading volume was 207K shares. The volume-weighted average price (VWAP) is $0.32.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Xtant Medical Holdings, Inc. has a market capitalization of $44.9 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. XTNT is listed on the XASE exchange. The company employs approximately 151 people. Xtant Medical Holdings, Inc. is headquartered in BELGRADE, MT. The recorded listing date is 2007-01-31.
On this page you can find market XTNT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.